Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Life Technologies Names Alan Sachs as Head of Global Research and Development

Published: Wednesday, February 01, 2012
Last Updated: Wednesday, February 01, 2012
Bookmark and Share
Sachs brings more than 20 years of experience as a research scientist and a leader in developing innovative scientific platforms.

The former Vice President, Exploratory and Translational Sciences for Merck Research Laboratories, has joined the company as Head of Global Research and Development.

Sachs will play a key role in driving technology strategy and further shaping Life Technologies' culture of high-performance R&D and product innovation. He will also lead the company's Global Science and Innovation Office and serve as the principal liaison to the external scientific community.

"Alan brings strong leadership qualities in research and development that's grounded in a deep understanding of biology – attributes that will be paramount to drive our efforts in developing innovative products for our customers," said Mark Stevenson, President and Chief Operating Officer at Life Technologies.

A former Associate Professor in the Division of Biochemistry and Molecular Biology at University of California, Berkeley, and Whitehead fellow at the Whitehead Institute for Biomedical Research, Sachs has published more than 70 papers in scientific journals. After a nine-year career in academia, he spent 10 years in leadership roles at Merck Research Laboratories, where he oversaw projects that included all aspects of molecular profiling, the development of RNA therapeutics, biomarker discovery for the pre-clinical and clinical markets, and human disease modeling.

Sachs received his Ph.D. in Cell Biology from Stanford University in 1987, his M.D. from the Stanford School of Medicine in 1989, and his B.A. in Biochemistry from Cornell University in 1982.
"Life Technologies has a strong legacy of being on the leading edge of technology that's designed to help researchers around the world move science forward," Sachs said. "I'm looking forward to being a part of that legacy and contributing new strategies to advance it even further."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Acquisition Approved by Life Technologies Stockholders
Company announced that its stockholders voted to adopt the previously announced merger agreement.
Thursday, August 22, 2013
Life Technologies Announces First Quarter 2013 Results
Revenue increased 2.5% to $963 million.
Friday, May 03, 2013
Life Technologies Acquires Compendia Bioscience
Acquisition of a preeminent cancer bioinformatics company enhance's Life's diagnostic development capabilities across multiple platforms
Sunday, November 11, 2012
Life Technologies introduces Ion AmpliSeq™ Community Panels
Ion AmpliSeq™ Community Panels leverages the expertise of scientific thought leaders and the Ion Community to create gene panels for conditions ranging from cancer to inherited diseases.
Wednesday, November 07, 2012
Life Technologies Acquires Compendia Bioscience
Acquisition expands Life Technologies' ability to drive progress in personalized medicine
Sunday, October 14, 2012
Scientific News
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Applying Deep Learning to Drug Discovery
Researchers train deep neural networks to predict the therapeutic use of large number of multiple drugs using gene expression data obtained from high-throughput experiments on human cell lines.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!